Clinical Trials Browser

Phase 1/2 × Opsoclonus-Myoclonus Syndrome × Rituximab × Clear all

NCT00244361 2011-05-10

Effectiveness of Rituximab in Pediatric OMS Patients.

Phase 1/2 Completed

Ataxia, Myoclonus, Ocular Motility Disorders, Opsoclonus-Myoclonus Syndrome